Schedule Of Prohibited Drugs

Canadian harness racing at Woodbine Mohawk Park

CPMA Prohibits Apomorphine, Adjusts Arsenic Threshold

The Canadian Pari-Mutuel Agency (CPMA) issued a memorandum on Wednesday, April 1, 2026 notifying the provincial regulatory bodies and the Canadian horse racing industry that it has officially added ap...

Canadian harness racing

Bupivacaine Added To Schedule Of Prohibited Drugs

The Canadian Pari-Mutuel Agency (CPMA) has officially added bupivacaine to paragraph 1(d) of the Schedule to the Pari-Mutuel Betting Supervision Regulations. This drug was previously prohibited under ...

%2Fcpma-logo_0.jpg

CPMA Issues Withdrawal Guideline Notice

On Thursday, April 7, the Canadian Pari-Mutuel Association issued a notice to the industry stating that the CPMA has received a number of inquiries from industry participants asking about the changes ...

CPMA Delays Implementation Of 2016 Elimination Guidelines

On Thursday, March 31, the Canadian Pari-Mutuel Association issued a release stating that the CPMA is delaying the implementation of the 2016 Elimination Guidelines until May 1, 2016 to allow addition...

Notice Regarding Buprenorphine

The Canadian Pari-Mutuel Agency has issued a notice to the harness racing industry regarding buprenorphine.

Reminder: Telmisartan Now Prohibited

September 02, 2014

On Tuesday, September 2, the Ontario Racing Commission issued a notice to the industry reminding everybody of the Canadian Pari-Mutuel Agency’s Memorandum to the Canadian racing industry and to Provin...

Telmisartan Added As Prohibited Drug

August 29, 2014

Please be advised that the regulatory amendment to add the drug telmisartan to the Canadian Pari-Mutuel Agency's (CPMA) Schedule to the Pari-Mutuel Betting Supervision Regulations has been finalized.